Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Robots Make Their Mark on Restaurant Industry

With automation seemingly taking a hold of almost every part of our daily routines, an industry known for adapting to fast service is beginning to transition into robotics. Many fast food chains have already started implementing touch screen menus and mobile ordering services that replace traditional person-to-person transactions, but the current state of automation in…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

With automation seemingly taking a hold of almost every part of our daily routines, an industry known for adapting to fast service is beginning to transition into robotics. Many fast food chains have already started implementing touch screen menus and mobile ordering services that replace traditional person-to-person transactions, but the current state of automation in restaurants is far more advanced than touch-screen ordering. In Boston, a restaurant has opened recently with a row of robotic cooks that looks to change the way customers eat fast food. 

Spyce, the product of four MIT graduates searching for a healthy, affordable alternative to fast food, uses a traditional commissary kitchen with humans to prep the ingredients. What makes Spyce special is their arsenal of seven robotic cooking woks that dispense ingredients the customer chooses on a touch screen menu, cooks them with induction heat in three minutes or less, and serves the final dish in a bowl that is garnished and delivered by employees. The idea is revolutionary, or as Spyce puts it, “We’re at the intersection of technology and hospitality, making accessible, tasty and nutritious meals.” 

Robotics are not only making food at trendy new restaurants—they are also now cooking meals at home.

Moley is a company that is looking to bring consumers into the future with “the world’s first automated and intelligent cooking robot.” Their idea incorporates a pair of robotic hands programmed with the movements and nuances of an award-winning chef. 

The consumer product—set to launch in 2018 will be, as described by Moley, Sophisticated yet compact, it will feature the four key integrated kitchen items of robotic arms, oven, hob and touchscreen unit. The kitchen is operated by its touch screen or remotely via smartphone. When not in use, the robotic arms retract from view. In robotic use, glass screens glide across the unit, enclosing it for safe use when there’s no-one home.”

How we get our food is rapidly changing, and whether it be at home or on the road, your next meal may be courtesy of advanced robotic engineering.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512